Optimizing Intensive Chemotherapy Management in Secondary AML Through Academic Community Collaboration - Episode 8
Panelists discuss how the decision to refer a patient with secondary AML from community practice to an academic or specialized leukemia program should be based on a combination of disease complexity, treatment requirements, and the community center's capabilities, while emphasizing the importance of ongoing collaboration and education to enhance patient care across all settings.
Video content above is prompted by the following: